April 2013 FDA Recall Drug by Legacy Pharmaceutical Packaging Llc
D-319-2013 - Labeling

This Class II drug recall was voluntarily initiated by Legacy Pharmaceutical Packaging Llc on April 22, 2013 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-319-2013

Reason for Recall
Labeling: Label Error on Declared Strength-The recalled product has a misprint on the Amoldipine 10 mg label, 5 mg is listed in the USP description. Tablet strength is 10 mg.
Initiated
04-22-2013
Reported
05-22-2013
Quantity
484,236 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Legacy Pharmaceutical Packaging LLC
Walmart Amlodipine Besylate Tablets, USP 10 mg, Rx only, 30 tablets, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY. Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ. Distributed by: Wal-Mart Stores, Inc., Bentonville, AR. Packaged by: Legacy Pharmaceutical Packaging, LLC, Earth City, MO. NDC 68645-445-70.

Batch or Lot Expiration Information

Lot# 130251, 130252, 130253 Exp date: 11/14